መነሻSDZ • SWX
add
Sandoz Group AG
የቀዳሚ መዝጊያ
CHF 36.71
የቀን ክልል
CHF 36.76 - CHF 37.45
የዓመት ክልል
CHF 26.25 - CHF 45.10
የገበያው አጠቃላይ ዋጋ
16.15 ቢ CHF
አማካይ መጠን
1.52 ሚ
የዋጋ/ገቢ ምጥጥን
-
የትርፍ ክፍያ
1.63%
ዋና ልውውጥ
SWX
ዜና ላይ
ፋይናንስ
የገቢ መግለጫ
ገቢ
የተጣራ ገቢ
(USD) | ዲሴም 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
ገቢ | 2.66 ቢ | 5.41% |
የሥራ ወጪ | 1.29 ቢ | 12.91% |
የተጣራ ገቢ | -75.00 ሚ | 5.06% |
የተጣራ የትርፍ ክልል | -2.82 | 9.90% |
ገቢ በሼር | — | — |
EBITDA | 96.50 ሚ | 91.09% |
ውጤታማ የግብር ተመን | 30.23% | — |
ቀሪ ሒሳብ ሉሆች
አጠቃላይ ንብረቶች
አጠቃላይ ተጠያቂነቶች
(USD) | ዲሴም 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
ጥሬ ገንዘብና የአጭር ጊዜ መዋዕለ ንዋይ | 1.19 ቢ | 7.39% |
አጠቃላይ ንብረቶች | 19.91 ቢ | 2.45% |
አጠቃላይ ተጠያቂነቶች | 11.74 ቢ | 8.97% |
አጠቃላይ እሴት | 8.16 ቢ | — |
የሼሮቹ ብዛት | 430.70 ሚ | — |
የገበያ ዋጋ እና የተገለጸ ዋጋ | 1.94 | — |
የእሴቶች ተመላሽ | -0.16% | — |
የካፒታል ተመላሽ | -0.24% | — |
የገንዘብ ፍሰት
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ
(USD) | ዲሴም 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
የተጣራ ገቢ | -75.00 ሚ | 5.06% |
ከክወናዎች የተገኘ ጥሬ ገንዘብ | 213.50 ሚ | 54.15% |
ገንዘብ ከኢንቨስትመንት | -173.00 ሚ | 18.97% |
ገንዘብ ከፋይናንስ | 235.00 ሚ | -56.48% |
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ | 245.00 ሚ | -50.10% |
ነፃ የገንዘብ ፍሰት | -85.38 ሚ | 38.74% |
ስለ
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkichen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
ዋና ሥራ አስፈጻሚ
የተመሰረተው
1886
ድህረገፅ
ሠራተኞች
22,049